Gene expression signatures for colorectal cancer microsatellite status and HNPCC
2005

Gene Expression Signatures for Colorectal Cancer Microsatellite Status

Sample size: 151 publication Evidence: high

Author Information

Author(s): Kruhøffer M, Jensen J L, Laiho P, Dyrskjøt L, Salovaara R, Arango D, Birkenkamp-Demtroder K, Sørensen F B, Christensen L L, Buhl L, Mecklin J-P, Järvinen H, Thykjaer T, Wikman F P, Bech-Knudsen F, Juhola M, Nupponen N N, Laurberg S, Andersen C L, Aaltonen L A, Ørntoft T F

Primary Institution: Aarhus University Hospital

Hypothesis

Can gene expression signatures be used to predict microsatellite instability (MSI) and hereditary nonpolyposis colorectal cancer (HNPCC) in colorectal cancer?

Conclusion

The study successfully developed a gene expression signature that can distinguish between microsatellite stable and unstable colorectal cancers, as well as between sporadic and hereditary cases.

Supporting Evidence

  • 34 out of 47 tumors were correctly classified as MSI or MSS using the gene expression signature.
  • The gene expression signature was validated on an independent test set.
  • MSI tumors were shown to have a better prognosis compared to MSS tumors.
  • Two genes, MLH1 and PIWIL1, were identified to differentiate between sporadic MSI and hereditary cases.
  • The study included a diverse sample set from multiple clinics.
  • Statistical tests confirmed the significance of the observed tumor classifications.
  • The classifier demonstrated a high sensitivity and specificity comparable to traditional methods.

Takeaway

Scientists found a way to tell if colon cancer is caused by genetics or just bad luck by looking at the genes in the cancer cells.

Methodology

The study profiled gene expression in 101 colorectal cancer samples using microarrays and validated findings with real-time RT-PCR on an independent set of 47 tumors.

Potential Biases

Potential bias due to the geographic origin of samples affecting gene expression patterns.

Limitations

The study's findings need to be confirmed in larger, independent cohorts.

Participant Demographics

Patients from Denmark and Finland, with a mix of sporadic and hereditary cancer cases.

Statistical Information

P-Value

0.0014

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602621

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication